Clinical Trial Update: Serplulimab Plus Chemotherapy for Early-stage HR+/HER2- Breast Cancer [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial evaluating serplulimab in combination with chemotherapy for early-stage HR+/HER2- breast cancer; the study is currently active …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Chemotherapy (chemotherapy)
• Serplulimab (serplulimab)

Snippet

Sponsor: Henan Cancer Hospital | Conditions: Breast Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING